Immunovant, Inc.
IMVTBiotechnology
$29.64+0.75%As of Oct 29vs prior close
- Market cap
- $6.1B
- P/E (TTM)
- –
- From 52W high
- −34.07%
- EPS (LTM)
- -$2.81
- Dividend yield
- 0.00%
Nomior Score
54
Steady ProfileTop 40% of the scored universe
Growth—
Quality44
Value—
Momentum75
Resilience46
Connections
Who owns it
2funds, 1 tracked portfolio